Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 103 | −1 |
| Shares | 24.0M | 10.3K | 25.4M | +1.47M (+6.2%) |
| Value | $116.5M | $50.0K | $114.1M | −$2.35M (−2.0%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 237,131 | $1.06M | 0.00% |
| Bridgeway Capital Management, LLC | 157,700 | $708.0K | 0.01% |
| Campbell & CO Investment Adviser LLC | 17,000 | $76.0K | 0.03% |
| Wolverine Trading, LLC | 14,044 | $62.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 12,526 | $56.0K | 0.00% |
| State of Wyoming | 12,561 | $56.0K | 0.03% |
| Dynamic Technology Lab Private Ltd | 10,657 | $48.0K | 0.01% |
| EverSource Wealth Advisors, LLC | 573 | $3.00K | 0.00% |
| Lenox Wealth Advisors, LLC | 500 | $2.00K | 0.00% |
| FinTrust Capital Advisors, LLC | 74 | $0 | 0.00% |
Sold out (11)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace, LLP | 111,547 | $542.0K |
| Jane Street Group, LLC | 24,392 | $119.0K |
| Millennium Management LLC | 22,313 | $108.0K |
| Virtus ETF Advisers LLC | 20,379 | $99.0K |
| HighVista Strategies LLC | 19,182 | $93.0K |
| Summit Global Investments | 18,600 | $90.0K |
| Kalos Management, Inc. | 15,550 | $77.0K |
| Essex Financial Services, Inc. | 13,800 | $67.0K |
| Jaffetilchin Investment Partners, LLC | 12,675 | $62.0K |
| Toth Financial Advisory Corp | 3,000 | $15.0K |
| Penserra Capital Management LLC | 1,110 | $5.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| HighPoint Advisor Group LLC | 10,277 | $50.0K |